Cargando…

Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation

BACKGROUND: Low-voltage-substrate (LVS)-guided ablation for persistent atrial fibrillation (AF) has been described either in sinus rhythm (SR) or AF. Prolonged fractionated potentials (PFPs) may represent arrhythmogenic slow conduction substrate and potentially co-localize with LVS. We assess the sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Taiyuan, Chen, Juan, Müller-Edenborn, Björn, Mayer, Louisa, Eichenlaub, Martin, Moreno Weidmann, Zoraida, Allgeier, Juergen, Bohnen, Marius, Lehrmann, Heiko, Trenk, Dietmar, Schoechlin, Simon, Westermann, Dirk, Arentz, Thomas, Jadidi, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622778/
https://www.ncbi.nlm.nih.gov/pubmed/36330001
http://dx.doi.org/10.3389/fcvm.2022.1000027
_version_ 1784821849826263040
author Huang, Taiyuan
Chen, Juan
Müller-Edenborn, Björn
Mayer, Louisa
Eichenlaub, Martin
Moreno Weidmann, Zoraida
Allgeier, Juergen
Bohnen, Marius
Lehrmann, Heiko
Trenk, Dietmar
Schoechlin, Simon
Westermann, Dirk
Arentz, Thomas
Jadidi, Amir
author_facet Huang, Taiyuan
Chen, Juan
Müller-Edenborn, Björn
Mayer, Louisa
Eichenlaub, Martin
Moreno Weidmann, Zoraida
Allgeier, Juergen
Bohnen, Marius
Lehrmann, Heiko
Trenk, Dietmar
Schoechlin, Simon
Westermann, Dirk
Arentz, Thomas
Jadidi, Amir
author_sort Huang, Taiyuan
collection PubMed
description BACKGROUND: Low-voltage-substrate (LVS)-guided ablation for persistent atrial fibrillation (AF) has been described either in sinus rhythm (SR) or AF. Prolonged fractionated potentials (PFPs) may represent arrhythmogenic slow conduction substrate and potentially co-localize with LVS. We assess the spatial correlation of PFP identified in AF (PFP-AF) to those mapped in SR (PFP-SR). We further report the relationship between LVS and PFPs when mapped in AF or SR. MATERIALS AND METHODS: Thirty-eight patients with ablation naïve persistent AF underwent left atrial (LA) high—density mapping in AF and SR prior to catheter ablation. Areas presenting PFP-AF and PFP-SR were annotated during mapping on the LA geometry. Low-voltage areas (LVA) were quantified using a bipolar threshold of 0.5 mV during both AF and SR mapping. Concordance of fractionated potentials (CFP) (defined as the presence of PFPs in both rhythms within a radius of 6 mm) was quantified. Spatial distribution and correlation of PFP and CFP with LVA were assessed. The predictors for CFP were determined. RESULTS: PFPs displayed low voltages both during AF (median 0.30 mV (Q1–Q3: 0.20–0.50 mV) and SR (median 0.35 mV (Q1–Q3: 0.20–0.56 mV). The duration of PFP-SR was measured at 61 ms (Q1–Q3: 51–76 ms). During SR, most PFP-SRs (89.4 and 97.2%) were located within LVA (<0.5 mV and <1.0 mV, respectively). Areas presenting PFP occurred more frequently in AF than in SR (median: 9.5 vs. 8.0, p = 0.005). Both PFP-AF and PFP-SR were predominantly located at anterior LA (>40%), followed by posterior LA (>20%) and septal LA (>15%). The extent of LVA < 0.5 mV was more extensive in AF (median: 25.2% of LA surface, Q1–Q3:16.6–50.5%) than in SR (median: 12.3%, Q1–Q3: 4.7–29.4%, p = 0.001). CFP in both rhythms occurred in 80% of PFP-SR and 59% of PFP-AF (p = 0.008). Notably, CFP was positively correlated to the extent of LVA in SR (p = 0.004), but not with LVA in AF (p = 0.226). Additionally, the extent of LVA < 0.5 mV in SR was the only significant predictor for CFP, with an optimal threshold of 16% predicting high (>80%) fractionation concordance in AF and SR. CONCLUSION: Substrate mapping in SR vs. AF reveals smaller areas of low voltage and fewer sites with PFP. PFP-SR are located within low-voltage areas in SR. There is a high degree of spatial agreement (80%) between PFP-AF and PFP-SR in patients with moderate LVA in SR (>16% of LA surface). These findings should be considered when substrate-based ablation strategies are applied in patients with the left atrial low-voltage substrate with recurrent persistent AF.
format Online
Article
Text
id pubmed-9622778
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96227782022-11-02 Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation Huang, Taiyuan Chen, Juan Müller-Edenborn, Björn Mayer, Louisa Eichenlaub, Martin Moreno Weidmann, Zoraida Allgeier, Juergen Bohnen, Marius Lehrmann, Heiko Trenk, Dietmar Schoechlin, Simon Westermann, Dirk Arentz, Thomas Jadidi, Amir Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Low-voltage-substrate (LVS)-guided ablation for persistent atrial fibrillation (AF) has been described either in sinus rhythm (SR) or AF. Prolonged fractionated potentials (PFPs) may represent arrhythmogenic slow conduction substrate and potentially co-localize with LVS. We assess the spatial correlation of PFP identified in AF (PFP-AF) to those mapped in SR (PFP-SR). We further report the relationship between LVS and PFPs when mapped in AF or SR. MATERIALS AND METHODS: Thirty-eight patients with ablation naïve persistent AF underwent left atrial (LA) high—density mapping in AF and SR prior to catheter ablation. Areas presenting PFP-AF and PFP-SR were annotated during mapping on the LA geometry. Low-voltage areas (LVA) were quantified using a bipolar threshold of 0.5 mV during both AF and SR mapping. Concordance of fractionated potentials (CFP) (defined as the presence of PFPs in both rhythms within a radius of 6 mm) was quantified. Spatial distribution and correlation of PFP and CFP with LVA were assessed. The predictors for CFP were determined. RESULTS: PFPs displayed low voltages both during AF (median 0.30 mV (Q1–Q3: 0.20–0.50 mV) and SR (median 0.35 mV (Q1–Q3: 0.20–0.56 mV). The duration of PFP-SR was measured at 61 ms (Q1–Q3: 51–76 ms). During SR, most PFP-SRs (89.4 and 97.2%) were located within LVA (<0.5 mV and <1.0 mV, respectively). Areas presenting PFP occurred more frequently in AF than in SR (median: 9.5 vs. 8.0, p = 0.005). Both PFP-AF and PFP-SR were predominantly located at anterior LA (>40%), followed by posterior LA (>20%) and septal LA (>15%). The extent of LVA < 0.5 mV was more extensive in AF (median: 25.2% of LA surface, Q1–Q3:16.6–50.5%) than in SR (median: 12.3%, Q1–Q3: 4.7–29.4%, p = 0.001). CFP in both rhythms occurred in 80% of PFP-SR and 59% of PFP-AF (p = 0.008). Notably, CFP was positively correlated to the extent of LVA in SR (p = 0.004), but not with LVA in AF (p = 0.226). Additionally, the extent of LVA < 0.5 mV in SR was the only significant predictor for CFP, with an optimal threshold of 16% predicting high (>80%) fractionation concordance in AF and SR. CONCLUSION: Substrate mapping in SR vs. AF reveals smaller areas of low voltage and fewer sites with PFP. PFP-SR are located within low-voltage areas in SR. There is a high degree of spatial agreement (80%) between PFP-AF and PFP-SR in patients with moderate LVA in SR (>16% of LA surface). These findings should be considered when substrate-based ablation strategies are applied in patients with the left atrial low-voltage substrate with recurrent persistent AF. Frontiers Media S.A. 2022-10-18 /pmc/articles/PMC9622778/ /pubmed/36330001 http://dx.doi.org/10.3389/fcvm.2022.1000027 Text en Copyright © 2022 Huang, Chen, Müller-Edenborn, Mayer, Eichenlaub, Moreno Weidmann, Allgeier, Bohnen, Lehrmann, Trenk, Schoechlin, Westermann, Arentz and Jadidi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Huang, Taiyuan
Chen, Juan
Müller-Edenborn, Björn
Mayer, Louisa
Eichenlaub, Martin
Moreno Weidmann, Zoraida
Allgeier, Juergen
Bohnen, Marius
Lehrmann, Heiko
Trenk, Dietmar
Schoechlin, Simon
Westermann, Dirk
Arentz, Thomas
Jadidi, Amir
Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation
title Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation
title_full Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation
title_fullStr Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation
title_full_unstemmed Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation
title_short Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation
title_sort validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—a high-density mapping study in persistent atrial fibrillation
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622778/
https://www.ncbi.nlm.nih.gov/pubmed/36330001
http://dx.doi.org/10.3389/fcvm.2022.1000027
work_keys_str_mv AT huangtaiyuan validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT chenjuan validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT mulleredenbornbjorn validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT mayerlouisa validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT eichenlaubmartin validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT morenoweidmannzoraida validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT allgeierjuergen validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT bohnenmarius validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT lehrmannheiko validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT trenkdietmar validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT schoechlinsimon validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT westermanndirk validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT arentzthomas validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation
AT jadidiamir validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation